Yan Xie

Years Active: 2017-2022
Publications (10 Years): 5

Shanghai University of Traditional Chinese Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai University of Traditional Chinese Medicine Sep 01 2012

China

Associate Research Fellow :: Research Center for Health and Nutrition

Publications

Yufan Guo, Shuo Liu, Fazhen Luo, Dongyun Tang, Tianshu Yang, Xiuru Yang, Yan Xie
A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer. Pharmaceutics 14 (2) (2022)
Shuo Liu, Rui Li, Jin Qian, Jiabin Sun, Guowen Li, Jianliang Shen, Yan Xie
Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles. Molecular pharmaceutics 17 (4) (2020)
Lujia Li, Qingxue Fu, Mengxin Xia, Lei Xin, Hongyi Shen, Guowen Li, Guang Ji, Qianchao Meng, Yan Xie
Inhibition of P-Glycoprotein Mediated Efflux in Caco-2 Cells by Phytic Acid. Journal of agricultural and food chemistry 66 (4) (2018)
Jianliang Shen, Han-Cheon Kim, Joy Wolfram, Chao-Feng Mu, Wei Zhang, Haoran Liu, Yan Xie, Junhua Mai, Hang Zhang, Zhi Li, Maria Guevara, Zong-Wan Mao, Haifa Shen
A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer. Nano letters 17 (5) (2017)
Bing Deng, Mengxin Xia, Jin Qian, Rui Li, Lujia Li, Jianliang Shen, Guowen Li, Yan Xie
Calcium Phosphate-Reinforced Reduction-Sensitive Hyaluronic Acid Micelles for Delivering Paclitaxel in Cancer Therapy. Molecular pharmaceutics 14 (6) (2017)

Yan Xie.css-eqlu8i{font-size:small;padding-left:4px;}